Filing Flows › Neuraxis (NRXS) › Q3 2026 › vs Q2 2026
Neuraxis (NRXS) Q3 2026 vs Q2 2026 (quarter over quarter)
Neuraxis's revenue rose $99K (+5%) from $1.9M in Q2 2026 to $2.0M in Q3 2026.
Neuraxis, Q3 2026: revenue $2.0M (+150% year over year), operating margin -324.4%, net loss $6.5M, operating cash flow −$2.3M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $1.9M | $99K | +5% |
| Other income, net | $33K | $39K | −$5K | -14% |
| Net loss | $6.5M | $2.1M | $4.5M | +214% |
| Costs & expenses | $8.6M | $4.1M | $4.6M | +112% |
| Operating costs | $8.6M | $4.1M | $4.6M | +112% |
| Cost of revenue | $272K | $273K | −$1K | -0.3% |
| Research & development | $289K | $274K | $14K | +5% |
| Sales & marketing | $1.0M | $861K | $140K | +16% |
| General & admin | $7.0M | $2.6M | $4.4M | +166% |
| Operating cash sources | $6.5M | $2.1M | $4.5M | +214% |
| Depreciation & amortization | $17K | $17K | $171 | +1% |
| Share-based compensation | $4.1M | $640K | $3.4M | +534% |
| Working capital & other | $203K | $400K | −$196K | -49% |
| Cash used in operations | $2.3M | $1.0M | $1.2M | +120% |
| Net loss absorbed | $6.5M | $2.1M | $4.5M | +214% |
Questions
How much did Neuraxis's revenue grow quarter over quarter in Q3 2026?
Neuraxis's revenue rose $99K (+5%) from $1.9M in Q2 2026 to $2.0M in Q3 2026.